AVITA Medical (NASDAQ:RCEL – Get Free Report) and Allurion Technologies (NYSE:ALUR – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation.
Profitability
This table compares AVITA Medical and Allurion Technologies’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| AVITA Medical | -95.47% | -194.69% | -60.67% |
| Allurion Technologies | -71.24% | N/A | -56.75% |
Analyst Recommendations
This is a breakdown of recent ratings and target prices for AVITA Medical and Allurion Technologies, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| AVITA Medical | 0 | 2 | 1 | 0 | 2.33 |
| Allurion Technologies | 0 | 1 | 3 | 1 | 3.00 |
Volatility & Risk
AVITA Medical has a beta of 1.54, meaning that its share price is 54% more volatile than the S&P 500. Comparatively, Allurion Technologies has a beta of -0.37, meaning that its share price is 137% less volatile than the S&P 500.
Earnings & Valuation
This table compares AVITA Medical and Allurion Technologies”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| AVITA Medical | $50.14 million | 6.80 | -$35.38 million | ($2.23) | -5.83 |
| Allurion Technologies | $34.75 million | 0.68 | -$80.61 million | ($0.48) | -0.76 |
AVITA Medical has higher revenue and earnings than Allurion Technologies. AVITA Medical is trading at a lower price-to-earnings ratio than Allurion Technologies, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
27.7% of AVITA Medical shares are owned by institutional investors. Comparatively, 21.4% of Allurion Technologies shares are owned by institutional investors. 1.8% of AVITA Medical shares are owned by insiders. Comparatively, 22.4% of Allurion Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Summary
Allurion Technologies beats AVITA Medical on 10 of the 15 factors compared between the two stocks.
About AVITA Medical
AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.
About Allurion Technologies
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
Receive News & Ratings for AVITA Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AVITA Medical and related companies with MarketBeat.com's FREE daily email newsletter.
